John Jordan

Chief Financial Officer at RNA Diagnostics, Inc.

John Jordan

John Jordan

Chief Financial Officer at RNA Diagnostics, Inc.

Overview
Career Highlights

RNA Diagnostics, Inc.

RelSci Relationships

18

Number of Boards

1

Relationships
RelSci Relationships are individuals John Jordan likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Executive Officer at RNA Diagnostics, Inc.

Relationship likelihood: Strong

Chief Operating Officer & Director at Steinberg Global Asset Management Ltd.

Relationship likelihood: Strong

Director at RNA Diagnostics, Inc.

Relationship likelihood: Strong

Executive Vice President Corporate Development at RNA Diagnostics, Inc.

Relationship likelihood: Strong

Chief Advisor at Relentless Pursuit Partners, Inc.

Relationship likelihood: Strong

Director at Ontario Genomics Institute (Private Equity)

Relationship likelihood: Strong

Chief Scientific Officer at RNA Diagnostics, Inc.

Relationship likelihood: Strong

Former Doctor at Mayo Clinic

Relationship likelihood: Strong

Director, Operations & R&D at RNA Diagnostics, Inc.

Relationship likelihood: Strong

Director of Clinical Development at RNA Diagnostics, Inc.

Relationship likelihood: Strong

Paths to John Jordan
Potential Connections via
Relationship Science
You
John Jordan
Chief Financial Officer at RNA Diagnostics, Inc.
Career History
Chief Financial Officer
Current

Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada.

Boards & Committees
Member, Board of Directors
Current

Rna Diagnostics, Inc. operates as a cancer diagnostics company which builds a platform of prognostic biomarker tools to help improve the lives of patients undergoing chemotherapy. The firm develops prognostic biomarker tools to improve the lives of women undergoing chemotherapy for breast cancer. It provides The RNA Disruption Assay (RDA), which provides physicians with an evaluation of how individual patients are responding to chemotherapy. The company was founded by Kenneth P. H. Pritzker in 2010 and is headquartered in Toronto, Canada.

Other Affiliations

John Jordan is affiliated with RNA Diagnostics, Inc., RNA Diagnostics, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by John Jordan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of John Jordan's profile does not indicate a business or promotional relationship of any kind between RelSci and John Jordan.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/john-jordan-214742994
  • https://relationshipscience.com/person/john-jordan-214742994